Skip to content

BAJAJ HEALTHCARE LTD

BAJAJ HEALTHCARE LTD

Linkedin Twitter
  • HOME
  • ABOUT US +
    • Overview
    • Mission & Vision
    • Management
    • CSR Policy
  • PRODUCTS
    • Intermediates
    • API
    • Formulation
    • Impurities
    • TO BE COMMERCIALIZED
      • API
    • Under Development
      • API
      • Formulation
  • MANUFACTURING
  • R&D
  • INVESTORS +
    • Disclosures under Regulation 46 of the LODR
      • Board Committee
      • Annual Financial Result >
        • Annual Financial Report 2010-11
        • Annual Financial Report 2011-12
        • Annual Financial Report 2012-13
        • Annual Financial Report 2013-14
        • Annual Financial Report 2014-15
        • Annual Financial Report 2015-16
        • Annual Financial Report 2016-17
        • Annual Financial Report 2017-18
        • Annual Financial Report 2018-19
        • Annual Financial Report 2019-20
        • Annual Financial Report 2020-21
        • Annual Financial Report 2021-22
        • Annual Financial Result 2022-23
        • Annual Financial Result 2023-24
      • Stock Exchange Intimation >
        • Stock Exchange Intimation 2016-17
        • Stock Exchange Intimation 2017-18
        • Stock Exchange Intimation 2018-19
        • Stock Exchange Intimation 2019-20
        • Stock Exchange Intimation 2020-21
        • Stock Exchange Intimation 2021-22
        • Stock Exchange Intimation 2022-23
        • Stock Exchange Intimation 2023-24
        • Stock Exchange Intimation 2024-25
        • Stock Exchange Intimation 2025-26
      • Corporate Governance >
        • Authorization to file with Stock Exchange
        • Policies
        • MOA & AOA
      • Notices >
        • Shareholder’s Meeting
        • Postal Ballot
      • Compliance Certificate
      • General Updates
      • Grievance Redressal
      • Investors Presentation
  • CAREERS
  • CONTACT US
Menu
  • HOME
  • ABOUT US +
    • Overview
    • Mission & Vision
    • Management
    • CSR Policy
  • PRODUCTS
    • Intermediates
    • API
    • Formulation
    • Impurities
    • TO BE COMMERCIALIZED
      • API
    • Under Development
      • API
      • Formulation
  • MANUFACTURING
  • R&D
  • INVESTORS +
    • Disclosures under Regulation 46 of the LODR
      • Board Committee
      • Annual Financial Result >
        • Annual Financial Report 2010-11
        • Annual Financial Report 2011-12
        • Annual Financial Report 2012-13
        • Annual Financial Report 2013-14
        • Annual Financial Report 2014-15
        • Annual Financial Report 2015-16
        • Annual Financial Report 2016-17
        • Annual Financial Report 2017-18
        • Annual Financial Report 2018-19
        • Annual Financial Report 2019-20
        • Annual Financial Report 2020-21
        • Annual Financial Report 2021-22
        • Annual Financial Result 2022-23
        • Annual Financial Result 2023-24
      • Stock Exchange Intimation >
        • Stock Exchange Intimation 2016-17
        • Stock Exchange Intimation 2017-18
        • Stock Exchange Intimation 2018-19
        • Stock Exchange Intimation 2019-20
        • Stock Exchange Intimation 2020-21
        • Stock Exchange Intimation 2021-22
        • Stock Exchange Intimation 2022-23
        • Stock Exchange Intimation 2023-24
        • Stock Exchange Intimation 2024-25
        • Stock Exchange Intimation 2025-26
      • Corporate Governance >
        • Authorization to file with Stock Exchange
        • Policies
        • MOA & AOA
      • Notices >
        • Shareholder’s Meeting
        • Postal Ballot
      • Compliance Certificate
      • General Updates
      • Grievance Redressal
      • Investors Presentation
  • CAREERS
  • CONTACT US

Policies

  • Risk Management Policy
  • Dividend Distribution Policy
  • Insider Trading Policy-BHCL
  • Corporate Social responsibility Policy -BHCL
  • CODE FOR UPSI
  • Archival policy-BHCL
  • POLICY ON PRESERVATION OF DOCUMENTS
  • FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS
  • POLICY FOR DETERMINATION OF MATERIALITY OF ANY EVENT / INFORMATION
  • WHISTLE BLOWER POLICY
  • TERMS AND CONDITIONS OF APPOINTMENT OF INDEPENDENT DIRECTORS
  • CODE OF CONDUCT
  • RELATED PARTY TRANSACTION POLICY
  • REMUNERATION POLICY

MENU

  • HOME
  • ABOUT US +
    • Overview
    • Mission & Vision
    • Management
    • CSR Policy
  • PRODUCTS
    • Intermediates
    • API
    • Formulation
    • Impurities
    • TO BE COMMERCIALIZED
      • API
    • Under Development
      • API
      • Formulation
  • MANUFACTURING
  • R&D
  • INVESTORS +
    • Disclosures under Regulation 46 of the LODR
      • Board Committee
      • Annual Financial Result >
      • Stock Exchange Intimation >
      • Corporate Governance >
      • Notices >
      • Compliance Certificate
      • General Updates
      • Grievance Redressal
      • Investors Presentation
  • CAREERS
  • CONTACT US